UnitedHealth Analysts Increase Their Forecasts After Better-Than-Expected Q2 Results

Benzinga Earnings
07/17

UnitedHealth Group Inc. (NYSE:UNH) on Thursday reported better-than-expected second-quarter results and raised its full-year 2026 earnings guidance.

Adjusted earnings came in at $6.38 per share, topping the analyst consensus estimate of $4.86. Revenue increased to $112.03 billion from $111.62 billion a year earlier and exceeded Wall Street expectations of $110.83 billion. GAAP earnings were $6.04 per share.

“Our results and outlook reflect the continuing progress in our work to simplify how we operate, improve both affordability and the health care experience for patients and care providers and apply modern technology to create real improvement for people,” said Stephen Hemsley, chief executive officer of UnitedHealth Group.

UnitedHealth shares gained 1.3% to trade at $428.75 on Friday.

These analysts made changes to their price targets on UnitedHealth following earnings announcement.

  • UBS analyst A.J. Rice maintained the stock with a Buy and raised the price target from $460 to $490.
  • RBC Capital analyst Ben Hendrix maintained UnitedHealth with an Outperform rating and boosted the price target from $463 to $478.
  • Truist Securities analyst David Macdonald maintained the stock with a Buy and raised the price target from $480 to $500.

Considering buying UNH stock? Here’s what analysts think:

Photo via Shutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10